Renal clearance of ifosfamide

Drug Metabolism and Disposition

Volumn 25, Issue 9, 1997, Pages 1081-1082

  Springate, James ^a,d   Zamlauski Tucker, Marianna J ^b   Hong, L U ^c   Chan, Kenneth K ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO STATE COLLEGE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IFOSFAMIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EXCRETION; DRUG METABOLISM; ISOLATED KIDNEY; KIDNEY CLEARANCE; KIDNEY METABOLISM; KIDNEY PERFUSION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; FEMALE; IFOSFAMIDE; KIDNEY; METABOLIC CLEARANCE RATE; PERFUSION; RATS; RATS, INBRED LEW;

ANIMALIA;

EID: 0030876403     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. R. Skinner, I. Sharkey, A. Pearson, and A. Croft: Ifosfamide, mesna and nephrotoxicity in children. J. Clin. Oncol. 11, 173-190 (1993).
2. P. Ho, K. Zimmerman, L. Wexler, S. Blaney, P. Jarosinski, L. Weaver-McClure, S. Izraeli, and F. Balis: A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer 76, 2557-2564 (1995).
3. G. Kaijser, J. Bejnen, A. Bult, and W. Underberg: Ifosfamide metabolism and pharmacokinetics. Anticancer Res. 14, 517-532 (1994).
4. M. Mohrmann, A. Pauli, M. Ritzer, B. Schonfeld, B. Seifert, and M. Brandis: Inhibition of sodium-dependent transport systems in LLC-PKI cells by metabolites of ifosfamide. Renal Physiol. iochem. 15, 289 301 (1992).
5. M. Mohrmann. S. Ansorge, U. Schmich. B. Schonfeld, and M. Brandis: Toxicity of ifosfamide. cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr. Nephrol. 8, 157-163 (1994).
6. M. Zamlauski-Tucker, M. Morris, and J. Springate: Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney. Toxicol. Appl. Pharmacol. 129, 170-175 (1994).
7. A. Boddy, M. English, A. Pearson, J. Idle, and R. Skinner: Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics. Eur. J. Cancer 32A, 1179-1184 (1996).
8. J. Fuhr. J. Kacmarczyk. and C. Kruttgen: Eine einfache colorimetrische methode zur inulin bestimmung für nieren-clearance-unter-suchungen bei Stoffwechsel- gelsunden und diabetekem. Pfflugers Arch. 267, 128-137 (1955).
9. J. Wang and K. Chan: Identification of new metabolites of ifosfamide in rat urine using ion cluster technique. J. Mass Spectmm. 30, 675-683 (1995).
10. N. Boyce and S. Holdsworth: Glomerular permsclectivity in the isolated perfused rat kidney. Am. J. Physiol. 249, F780-F784 (1985).
11. T. Maack: Renal clearance and isolated kidney perfusion techniques. Kidney Int. 30, 142-151 (1986).
12. M. Aleo. M. Taub, J. Olson. and P. Kostyniak: Primary cultures of rabbit renal proximal tubule cells: II. Selected phase I and phase II metabolic capacities. Toxicol. In Vitro 4, 727-733 (1990).